|
|
||||||||
1 Department of Virus and Cell Biology, Merck Research Laboratories, Sumneytown Pike, West Point, Pennsylvania 19486
2 Division of Infectious Diseases, Indiana University School of Medicine and Roudebush Veterans Administration Medical Center, Indianapolis, Indiana 46202-5124
and3 Loyola University Medical Center, Maywood, Illinois 60153, USA
The major capsid protein L1 of human papillomaviruses (HPVs) has been identified as a promising candidate antigen for a prophylactic HPV vaccine. Since amino acid sequence heterogeneity has been demonstrated for the L1 genes within individual HPV types, nucleotide sequences for L1 were determined from six HPV-18 clinical isolates and the cervical carcinoma cell line SW756 and compared to the published HPV-18 prototype sequence. The sequences were almost identical between the clinical isolates and SW756 but differed markedly from the published prototype sequence. Resequencing the prototype HPV-18 revealed that these differences were due to sequencing artifacts of the prototype HPV-18 sequence archived in GenBank. Thus, the HPV-18 L1 genes seem to display a very high level of sequence conservation. The HPV-18 L1 gene derived from SW756 was expressed in Saccharomyces cerevisiae and self-assembly of the L1 protein into viruslike particles was demonstrated.
* Author for correspondence. Fax +1 215 652 2142. e-mail Kathrin-Jansen@Merck.com
Received 22 August 1995;
accepted 31 October 1995.
This article has been cited by other articles:
![]() |
D. Dias, J. Van Doren, S. Schlottmann, S. Kelly, D. Puchalski, W. Ruiz, P. Boerckel, J. Kessler, J. M. Antonello, T. Green, et al. Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18 Clin. Vaccine Immunol., August 1, 2005; 12(8): 959 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Opalka, C. E. Lachman, S. A. MacMullen, K. U. Jansen, J. F. Smith, N. Chirmule, and M. T. Esser Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay Clin. Vaccine Immunol., January 1, 2003; 10(1): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-N. Zhao and I. H. Frazer Saccharomyces cerevisiae Is Permissive for Replication of Bovine Papillomavirus Type 1 J. Virol., October 25, 2002; 76(23): 12265 - 12273. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |